Regimbeau Jean-Marc, Kianmanesh Reza, Farges Olivier, Dondero Federica, Sauvanet Alain, Belghiti Jacques
Department of Hepatobiliary and Digestive Surgery, Beaujon Hospital, University of Paris VII, Clichy, France.
Surgery. 2002 Mar;131(3):311-7. doi: 10.1067/msy.2002.121892.
The long-term outcome after resection of hepatocellular carcinoma (HCC) is influenced by parameters related to the tumor and the underlying liver disease. However, the extent of the resection, which can be limited or anatomical (including the tumor and its portal territory), is controversial.
Among 64 Child-Pugh A patients with cirrhosis who underwent curative liver resection for small HCC (< or = 4 cm) between 1990 and 1996, 34 patients underwent limited resection with a margin width of at least 1 cm, and 30 patients underwent anatomic resection of at least 1 liver segment with complete removal of the portal area containing the tumor. The 2 groups were comparable in terms of epidemiologic and pathologic parameters. The major end points were: (1) in-hospital mortality and morbidity; (2) overall and disease-free survival; and (3) rate and topography of recurrence.
The 30-day mortality (6% vs 7%) and morbidity (52% vs 47%) rates after limited and anatomic liver resection were not statistically different. The 5- and 8-year overall survival rates after limited versus anatomic resection were, respectively, 35% versus 54% (P <.05) and 6% versus 45% (P <.05). The 5- and 8-year disease-free survival rates were, respectively, 26% versus 45% and 0% versus 21% (P <.05). Local recurrence was more frequently observed after limited resections than after anatomic resections (50% vs 10%, P <.05).
In patients with cirrhosis and a small HCC, anatomic resection achieves better disease-free survival than limited resection without increasing the postoperative risk. Therefore, anatomical resection should be the treatment of choice and considered as the reference surgical treatment compared with other treatments.
肝细胞癌(HCC)切除术后的长期预后受肿瘤及潜在肝脏疾病相关参数的影响。然而,切除范围(可分为局限性或解剖性,解剖性切除包括肿瘤及其门静脉区域)存在争议。
在1990年至1996年间接受小肝癌(≤4 cm)根治性肝切除的64例Child-Pugh A级肝硬化患者中,34例行切缘宽度至少为1 cm的局限性切除,30例行至少1个肝段的解剖性切除并完全清除包含肿瘤的门静脉区域。两组在流行病学和病理参数方面具有可比性。主要终点包括:(1)住院死亡率和发病率;(2)总生存率和无病生存率;(3)复发率和复发部位。
局限性肝切除和解剖性肝切除后的30天死亡率(6%对7%)和发病率(52%对47%)无统计学差异。局限性切除与解剖性切除后的5年和8年总生存率分别为35%对54%(P<.05)和6%对45%(P<.05)。5年和8年无病生存率分别为26%对45%和0%对21%(P<.05)。局限性切除后局部复发比解剖性切除更常见(50%对10%,P<.05)。
对于肝硬化合并小肝癌患者,解剖性切除比局限性切除能获得更好的无病生存率,且不增加术后风险。因此,解剖性切除应作为首选治疗方法,并与其他治疗方法相比被视为参考性手术治疗。